Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition Post author: Post published:July 4, 2024 Post category:uncategorized HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. You Might Also Like Macrophages use bacteria to build vital nutrients and control inflammation February 27, 2025 Study reveals decline in adolescent marijuana use over a decade October 28, 2024 ERC Advanced grant awarded to crack the code of cartilage repair April 12, 2024